4.7 Review

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

Journal

NATURE IMMUNOLOGY
Volume 10, Issue 3, Pages 241-247

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.1703

Keywords

-

Categories

Funding

  1. National Institutes of Health
  2. Arthritis Foundation
  3. Jung-Stiftung fur Wissenschaft und Forschung
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064748, R01AI063331] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052756] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The inflammasome is a multiprotein complex that mediates the activation of caspase-1, which promotes secretion of the proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18, as well as 'pyroptosis', a form of cell death induced by bacterial pathogens. Members of the Nod-like receptor family, including NLRP1, NLRP3 and NLRC4, and the adaptor ASC are critical components of the inflammasome that link microbial and endogenous 'danger' signals to caspase-1 activation. Several diseases are associated with dysregulated activation of caspase-1 and secretion of IL-1 beta. Thus, understanding inflammasome pathways may provide insight into disease pathogenesis that might identify potential targets for therapeutic intervention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available